Thomas Kieran Curry, MD | |
1450 5th St Se # 220, Puyallup, WA 98372-4602 | |
(253) 697-3200 | |
Not Available |
Full Name | Thomas Kieran Curry |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 33 Years |
Location | 1450 5th St Se # 220, Puyallup, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811974652 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Providence St Peter Hospital | Olympia, WA | Hospital |
Providence Centralia Hospital | Centralia, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health And Services Washington | 6709782600 | 393 |
News Archive
Peregrine Pharmaceuticals has reported that preclinical data presented at the Centennial Annual Meeting of the American Association for Cancer Research (AACR) showed that its monoclonal antibody 2C3, which selectively blocks vascular endothelial growth factor (VEGF) from binding to the second of the two VEGF receptors, demonstrates potent anti-cancer efficacy in a preclinical orthotopic model of pancreatic cancer.
NHS Blood and Transplant today, Thursday 25 April 2019, launches the year-long national campaign, ‘Pass it on', to increase awareness and understanding of the new organ donation law – Max and Keira's Law – which comes into place next year, across England.
A small but significant percentage of children develop acute kidney injury after taking nonsteroidal anti-inflammatory drugs such as ibuprofen, show study findings published in the Journal of Pediatrics.
Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI's former third-party reimbursement consultant for CTI's product TRISENOX, in 2007 seeking $22.8 million in damages for expenses already incurred related to the investigation, defense and a settlement of claims by the U.S. government concerning Medicare reimbursement for TRISENOX and other business losses.
› Verified 1 days ago
Entity Name | Providence Health & Services Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
Peregrine Pharmaceuticals has reported that preclinical data presented at the Centennial Annual Meeting of the American Association for Cancer Research (AACR) showed that its monoclonal antibody 2C3, which selectively blocks vascular endothelial growth factor (VEGF) from binding to the second of the two VEGF receptors, demonstrates potent anti-cancer efficacy in a preclinical orthotopic model of pancreatic cancer.
NHS Blood and Transplant today, Thursday 25 April 2019, launches the year-long national campaign, ‘Pass it on', to increase awareness and understanding of the new organ donation law – Max and Keira's Law – which comes into place next year, across England.
A small but significant percentage of children develop acute kidney injury after taking nonsteroidal anti-inflammatory drugs such as ibuprofen, show study findings published in the Journal of Pediatrics.
Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI's former third-party reimbursement consultant for CTI's product TRISENOX, in 2007 seeking $22.8 million in damages for expenses already incurred related to the investigation, defense and a settlement of claims by the U.S. government concerning Medicare reimbursement for TRISENOX and other business losses.
› Verified 1 days ago
Entity Name | Providence Health & Services Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619176997 PECOS PAC ID: 7719873496 Enrollment ID: O20040227000744 |
News Archive
Peregrine Pharmaceuticals has reported that preclinical data presented at the Centennial Annual Meeting of the American Association for Cancer Research (AACR) showed that its monoclonal antibody 2C3, which selectively blocks vascular endothelial growth factor (VEGF) from binding to the second of the two VEGF receptors, demonstrates potent anti-cancer efficacy in a preclinical orthotopic model of pancreatic cancer.
NHS Blood and Transplant today, Thursday 25 April 2019, launches the year-long national campaign, ‘Pass it on', to increase awareness and understanding of the new organ donation law – Max and Keira's Law – which comes into place next year, across England.
A small but significant percentage of children develop acute kidney injury after taking nonsteroidal anti-inflammatory drugs such as ibuprofen, show study findings published in the Journal of Pediatrics.
Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI's former third-party reimbursement consultant for CTI's product TRISENOX, in 2007 seeking $22.8 million in damages for expenses already incurred related to the investigation, defense and a settlement of claims by the U.S. government concerning Medicare reimbursement for TRISENOX and other business losses.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Thomas Kieran Curry, MD 128 Lilly Rd Ne, Ste 205, Olympia, WA 98506-7400 Ph: (253) 697-3200 | Thomas Kieran Curry, MD 1450 5th St Se # 220, Puyallup, WA 98372-4602 Ph: (253) 697-3200 |
News Archive
Peregrine Pharmaceuticals has reported that preclinical data presented at the Centennial Annual Meeting of the American Association for Cancer Research (AACR) showed that its monoclonal antibody 2C3, which selectively blocks vascular endothelial growth factor (VEGF) from binding to the second of the two VEGF receptors, demonstrates potent anti-cancer efficacy in a preclinical orthotopic model of pancreatic cancer.
NHS Blood and Transplant today, Thursday 25 April 2019, launches the year-long national campaign, ‘Pass it on', to increase awareness and understanding of the new organ donation law – Max and Keira's Law – which comes into place next year, across England.
A small but significant percentage of children develop acute kidney injury after taking nonsteroidal anti-inflammatory drugs such as ibuprofen, show study findings published in the Journal of Pediatrics.
Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI's former third-party reimbursement consultant for CTI's product TRISENOX, in 2007 seeking $22.8 million in damages for expenses already incurred related to the investigation, defense and a settlement of claims by the U.S. government concerning Medicare reimbursement for TRISENOX and other business losses.
› Verified 1 days ago
Dr. Cholwoo Anthony Kim, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Dr. Douglas R. King, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Dr. Kenneth A. Feucht, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-445-1844 Fax: 253-841-9701 | |
Brian Nelson, Surgery Medicare: Accepting Medicare Assignments Practice Location: 208 17th Ave Se, Puyallup, WA 98372 Phone: 253-840-1999 | |
Dr. Chia J. Chung, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 105 27th Ave Se, Puyallup, WA 98374 Phone: 253-848-8110 Fax: 253-845-3561 | |
Miles Mcbride Dale, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1519 3rd St Se Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Robert Charles Wright, MD FACS Surgery Medicare: Accepting Medicare Assignments Practice Location: 208 17th Ave Se, Suite 201, Puyallup, WA 98372 Phone: 253-840-1999 Fax: 253-445-4125 |